These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioadhesive mannosylated nanoparticles for oral drug delivery. Salman HH; Gamazo C; Campanero MA; Irache JM J Nanosci Nanotechnol; 2006; 6(9-10):3203-9. PubMed ID: 17048537 [TBL] [Abstract][Full Text] [Related]
3. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Arbós P; Arangoa MA; Campanero MA; Irache JM Int J Pharm; 2002 Aug; 242(1-2):129-36. PubMed ID: 12176235 [TBL] [Abstract][Full Text] [Related]
4. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. Agüeros M; Areses P; Campanero MA; Salman H; Quincoces G; Peñuelas I; Irache JM Eur J Pharm Sci; 2009 Jun; 37(3-4):231-40. PubMed ID: 19491010 [TBL] [Abstract][Full Text] [Related]
5. Bioadhesive properties of Gantrez nanoparticles. Irache JM; Huici M; Konecny M; Espuelas S; Campanero MA; Arbos P Molecules; 2005 Jan; 10(1):126-45. PubMed ID: 18007282 [TBL] [Abstract][Full Text] [Related]
6. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734 [TBL] [Abstract][Full Text] [Related]
7. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles. Salman HH; Gamazo C; Agüeros M; Irache JM Vaccine; 2007 Nov; 25(48):8123-32. PubMed ID: 18029067 [TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Salman HH; Irache JM; Gamazo C Vaccine; 2009 Jul; 27(35):4784-90. PubMed ID: 19539576 [TBL] [Abstract][Full Text] [Related]
9. Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination. Vandamme K; Melkebeek V; Cox E; Deforce D; Lenoir J; Adriaens E; Vervaet C; Remon JP Eur J Pharm Biopharm; 2010 Feb; 74(2):202-8. PubMed ID: 19819332 [TBL] [Abstract][Full Text] [Related]
10. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Behrens I; Pena AI; Alonso MJ; Kissel T Pharm Res; 2002 Aug; 19(8):1185-93. PubMed ID: 12240945 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles. Salman HH; Gamazo C; de Smidt PC; Russell-Jones G; Irache JM Pharm Res; 2008 Dec; 25(12):2859-68. PubMed ID: 18679774 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration. Patel MD; Date PV; Gaikwad RV; Samad A; Malshe VC; Devarajan PV J Biomed Nanotechnol; 2014 Apr; 10(4):687-94. PubMed ID: 24734521 [TBL] [Abstract][Full Text] [Related]
13. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. Arbós P; Campanero MA; Arangoa MA; Renedo MJ; Irache JM J Control Release; 2003 Apr; 89(1):19-30. PubMed ID: 12695060 [TBL] [Abstract][Full Text] [Related]
14. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Yoncheva K; Lizarraga E; Irache JM Eur J Pharm Sci; 2005 Apr; 24(5):411-9. PubMed ID: 15784331 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. Arbós P; Campanero MA; Arangoa MA; Irache JM J Control Release; 2004 Apr; 96(1):55-65. PubMed ID: 15063029 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of Gantrez®AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli. Vandamme K; Melkebeek V; Cox E; Remon JP; Vervaet C Vet Immunol Immunopathol; 2011 Feb; 139(2-4):148-55. PubMed ID: 21130503 [TBL] [Abstract][Full Text] [Related]
17. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of biodegradable nanoparticles entrapping immunodominant peptide conjugated with PEG for oral tolerance induction. Lee WK; Park JY; Jung S; Yang CW; Kim WU; Kim HY; Park JH; Park JS J Control Release; 2005 Jun; 105(1-2):77-88. PubMed ID: 15919128 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Yoncheva K; Guembe L; Campanero MA; Irache JM Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. Ojer P; Neutsch L; Gabor F; Irache JM; López de Cerain A J Biomed Nanotechnol; 2013 Nov; 9(11):1891-903. PubMed ID: 24059088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]